These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 32075687)
1. Circulating 27-hydroxycholesterol and breast cancer tissue expression of CYP27A1, CYP7B1, LXR-β, and ERβ: results from the EPIC-Heidelberg cohort. Le Cornet C; Walter B; Sookthai D; Johnson TS; Kühn T; Herpel E; Kaaks R; Fortner RT Breast Cancer Res; 2020 Feb; 22(1):23. PubMed ID: 32075687 [TBL] [Abstract][Full Text] [Related]
2. Circulating 27-Hydroxycholesterol and Breast Cancer Risk: Results From the EPIC-Heidelberg Cohort. Lu DL; Le Cornet C; Sookthai D; Johnson TS; Kaaks R; Fortner RT J Natl Cancer Inst; 2019 Apr; 111(4):365-371. PubMed ID: 30016454 [TBL] [Abstract][Full Text] [Related]
3. Impact of 27-hydroxylase (CYP27A1) and 27-hydroxycholesterol in breast cancer. Kimbung S; Chang CY; Bendahl PO; Dubois L; Thompson JW; McDonnell DP; Borgquist S Endocr Relat Cancer; 2017 Jul; 24(7):339-349. PubMed ID: 28442559 [TBL] [Abstract][Full Text] [Related]
4. Association between lifestyle, dietary, reproductive, and anthropometric factors and circulating 27-hydroxycholesterol in EPIC-Heidelberg. Le Cornet C; Johnson TS; Lu DL; Kaaks R; Fortner RT Cancer Causes Control; 2020 Feb; 31(2):181-192. PubMed ID: 31938951 [TBL] [Abstract][Full Text] [Related]
5. CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients. Kimbung S; Inasu M; Stålhammar T; Nodin B; Elebro K; Tryggvadottir H; Ygland Rödström M; Jirström K; Isaksson K; Jernström H; Borgquist S Breast Cancer Res; 2020 Nov; 22(1):123. PubMed ID: 33176848 [TBL] [Abstract][Full Text] [Related]
6. Vitamin D supplementation decreases serum 27-hydroxycholesterol in a pilot breast cancer trial. Going CC; Alexandrova L; Lau K; Yeh CY; Feldman D; Pitteri SJ Breast Cancer Res Treat; 2018 Feb; 167(3):797-802. PubMed ID: 29116467 [TBL] [Abstract][Full Text] [Related]
7. 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology. Nelson ER; Wardell SE; Jasper JS; Park S; Suchindran S; Howe MK; Carver NJ; Pillai RV; Sullivan PM; Sondhi V; Umetani M; Geradts J; McDonnell DP Science; 2013 Nov; 342(6162):1094-8. PubMed ID: 24288332 [TBL] [Abstract][Full Text] [Related]
8. On the regulatory importance of 27-hydroxycholesterol in mouse liver. Heverin M; Ali Z; Olin M; Tillander V; Joibari MM; Makoveichuk E; Leitersdorf E; Warner M; Olivercrona G; Gustafsson JÅ; Björkhem I J Steroid Biochem Mol Biol; 2017 May; 169():10-21. PubMed ID: 26851362 [TBL] [Abstract][Full Text] [Related]
9. 27-Hydroxycholesterol acts on myeloid immune cells to induce T cell dysfunction, promoting breast cancer progression. Ma L; Wang L; Nelson AT; Han C; He S; Henn MA; Menon K; Chen JJ; Baek AE; Vardanyan A; Shahoei SH; Park S; Shapiro DJ; Nanjappa SG; Nelson ER Cancer Lett; 2020 Nov; 493():266-283. PubMed ID: 32861706 [TBL] [Abstract][Full Text] [Related]
11. Role of 27-hydroxycholesterol and its metabolism in cancer progression: Human studies. Biasi F; Leoni V; Gamba P; Sassi K; Lizard G; Poli G Biochem Pharmacol; 2022 Feb; 196():114618. PubMed ID: 34023292 [TBL] [Abstract][Full Text] [Related]
12. Increased 27-hydroxycholesterol production during luteolysis may mediate the progressive decline in progesterone secretion. Xu Y; Hutchison SM; Hernández-Ledezma JJ; Bogan RL Mol Hum Reprod; 2018 Jan; 24(1):2-13. PubMed ID: 29177442 [TBL] [Abstract][Full Text] [Related]
13. Our evolving understanding of how 27-hydroxycholesterol influences cancer. Ma L; Cho W; Nelson ER Biochem Pharmacol; 2022 Feb; 196():114621. PubMed ID: 34043965 [TBL] [Abstract][Full Text] [Related]
14. The cholesterol metabolite 27-hydroxycholesterol promotes atherosclerosis via proinflammatory processes mediated by estrogen receptor alpha. Umetani M; Ghosh P; Ishikawa T; Umetani J; Ahmed M; Mineo C; Shaul PW Cell Metab; 2014 Jul; 20(1):172-82. PubMed ID: 24954418 [TBL] [Abstract][Full Text] [Related]
15. Circulating 27-hydroxycholesterol, lipids, and steroid hormones in breast cancer risk: a nested case-control study of the Multiethnic Cohort Study. DeRouen MC; Yang J; Li Y; Franke AA; Tome AN; White KK; Hernandez BY; Shvetsov Y; Setiawan V; Wu AH; Wilkens LR; Le Marchand L; Loo LWM; Cheng I Breast Cancer Res; 2023 Aug; 25(1):95. PubMed ID: 37580793 [TBL] [Abstract][Full Text] [Related]
16. Estrogen Receptor Beta-Mediated Modulation of Lung Cancer Cell Proliferation by 27-Hydroxycholesterol. Hiramitsu S; Ishikawa T; Lee WR; Khan T; Crumbley C; Khwaja N; Zamanian F; Asghari A; Sen M; Zhang Y; Hawse JR; Minna JD; Umetani M Front Endocrinol (Lausanne); 2018; 9():470. PubMed ID: 30190703 [TBL] [Abstract][Full Text] [Related]
17. [Interaction among peroxisome proliferators-activated receptor alpha, cytochrome P450 oxysterol 7α-hydroxylase and estrogen receptor and its association with intrahepatic cholestasis in pregnant rats]. Shi QY; Lin YG; Zhou X; Lin YQ; Yan S Zhonghua Fu Chan Ke Za Zhi; 2010 Jun; 45(6):440-4. PubMed ID: 21029595 [TBL] [Abstract][Full Text] [Related]
18. Host CYP27A1 expression is essential for ovarian cancer progression. He S; Ma L; Baek AE; Vardanyan A; Vembar V; Chen JJ; Nelson AT; Burdette JE; Nelson ER Endocr Relat Cancer; 2019 Jul; 26(7):659-675. PubMed ID: 31048561 [TBL] [Abstract][Full Text] [Related]
19. The impact of 27-hydroxycholesterol on endometrial cancer proliferation. Gibson DA; Collins F; Cousins FL; Esnal Zufiaurre A; Saunders PTK Endocr Relat Cancer; 2018 Apr; 25(4):381-391. PubMed ID: 29371332 [TBL] [Abstract][Full Text] [Related]
20. Involvement of 27-hydroxycholesterol on the progression of non-small cell lung cancer via the estrogen receptor. Takada I; Miyazaki T; Goto Y; Kanzawa H; Matsubara T; Namikawa-Kanai H; Shigefuku S; Ono S; Nakajima E; Morishita Y; Honda A; Furukawa K; Ikeda N Am J Cancer Res; 2022; 12(9):4241-4253. PubMed ID: 36225627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]